Table 1.

Distributions for selected characteristics of the prostate cancer patient cohort by recurrence status

Recurrence (n = 104)No recurrence (n = 303)
Characteristicn (%)n (%)
Age at diagnosis, y
 35–5433 (31.7)92 (30.4)
 55–5918 (17.3)77 (25.4)
 60–6434 (32.7)86 (28.4)
 65–6912 (11.5)28 (9.2)
 70–747 (6.7)20 (6.6)
  Mean age (± SE)58.5 (7.18)58.2 (7.10)
PSA at diagnosis, ng/mL
 0–3.913 (12.5)54 (17.8)
 4–9.945 (43.3)189 (62.4)
 10–19.924 (23.1)28 (9.2)
 20 +15 (14.4)14 (4.6)
 Missing7 (6.7)18 (5.9)
Pathologic stage
 Local47 (45.2)235 (77.6)
 Regional57 (54.8)68 (22.4)
Gleason score
 2–58 (7.7)37 (12.2)
 616 (15.4)136 (44.9)
 7 (3 + 4)45 (43.3)101 (33.3)
 7 (4 + 3)17 (16.4)16 (5.3)
 8–1018 (17.3)13 (4.3)